IL-33/ST2 axis in autoimmune disease

Area of Science:

• Immunology
• Autoimmune Diseases

Background:

• Interleukin-33 (IL-33), an IL-1 family member, signals through the ST2 receptor.
• IL-33 influences various immune cells, including mast cells, basophils, eosinophils, NK cells, and T lymphocytes.
• Aberrant IL-33 activity is implicated in numerous inflammatory and immune-mediated conditions like MS, RA, SLE, psoriasis, Sjogren's syndrome, and IBD.

Purpose of the Study:

• To review selected studies on the IL-33/ST2 axis in autoimmune diseases.
• To discuss the dual role of IL-33 as a pathogenic or protective cytokine in these conditions.

Main Methods:

• Literature review of studies investigating the IL-33/ST2 axis.
• Analysis of IL-33's role in specific autoimmune and metabolic diseases.

Main Results:

• The IL-33/ST2 axis can promote pro-inflammatory cytokine release in autoimmune diseases.
• Conversely, IL-33 may exhibit anti-inflammatory properties in certain metabolic diseases, such as type 1 diabetes mellitus.

Conclusions:

• The IL-33/ST2 axis presents a complex and context-dependent role in autoimmune pathogenesis.
• Further research is needed to fully elucidate IL-33's therapeutic potential in immune-mediated disorders.